The Oncology Medical Study and Investigation Clinic aims at the provision of all standard or new, approved, innovative, targeted and personalized therapies in the field of oncology and the provision of authoritative research, diagnosis, approach and treatment methods in oncology issues, through cooperation with Metropolitan General Departments and Services, our Group Hospitals as well as university medical institutions/departments or oncology centers.
The Oncology Medical Study and Investigation Clinic was founded with the objective to deal with the needs of patients and their human environment facing oncology issues on a four-pillar basis:
- The availability of advisable, standard and internationally accepted diagnostic and treatment approaches to each disease.
- The participation in highly-renowned international oncology clinical studies.
- Early access to treatments demonstrated to be effective, even if not currently in circulation in our country, through free-o-charge early access programs.
- Participation in research programs such as the promotion or detection of benchmarks in the correct and effective choice of therapies.
INTERNATIONAL CLINICAL STUDIES
Our Oncology Medical Study and Investigation Clinic participates in a significant number of clinical studies regarding patients suffering from metastatic prostate cancer, metastatic colorectal cancer, metastatic kidney cancer, bladder/urothelial cancer, microcytic (small-cell) lung cancer and other oncological diseases.
The Clinical Study Team consists of:
Evangelos Bournakis, Pathologist Oncologist, Director of the Oncology Medical Study and Investigation Clinic
Angeliki Sfika, Pathologist-Oncologist
Nikolaos Soupos, Pathologist-Oncologist
Nikoalos Skandalakis, Cardiologist
Athanasios Bournakis MSc, Chemical Engineer
Stamatia Kotsia, Director of the Brief Hospitalization Department at Metropolitan General
Evangelos Bournakis, Oncologist
Aggeliki Sfika, Oncologist
Nikolaos Soupos, Oncologist
Nikolaos Skandalakis, Cardiologist
Contact number: +30 210 650 2831